EP1781173A1 - Verfahren zur selektiven sterilisation von diagnostischen testelementen - Google Patents
Verfahren zur selektiven sterilisation von diagnostischen testelementenInfo
- Publication number
- EP1781173A1 EP1781173A1 EP05764074A EP05764074A EP1781173A1 EP 1781173 A1 EP1781173 A1 EP 1781173A1 EP 05764074 A EP05764074 A EP 05764074A EP 05764074 A EP05764074 A EP 05764074A EP 1781173 A1 EP1781173 A1 EP 1781173A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- lancing
- region
- detection
- area
- test
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 49
- 238000002405 diagnostic procedure Methods 0.000 title claims abstract description 28
- 238000004659 sterilization and disinfection Methods 0.000 title abstract description 58
- 238000001514 detection method Methods 0.000 claims abstract description 124
- 238000012360 testing method Methods 0.000 claims abstract description 118
- 230000005855 radiation Effects 0.000 claims abstract description 52
- 210000001124 body fluid Anatomy 0.000 claims abstract description 26
- 239000012491 analyte Substances 0.000 claims abstract description 25
- 239000010839 body fluid Substances 0.000 claims abstract description 24
- 238000004519 manufacturing process Methods 0.000 claims abstract description 18
- 230000032258 transport Effects 0.000 claims description 20
- 238000004806 packaging method and process Methods 0.000 claims description 17
- 244000052616 bacterial pathogen Species 0.000 claims description 16
- 239000000463 material Substances 0.000 claims description 8
- 230000035515 penetration Effects 0.000 claims description 6
- 238000012216 screening Methods 0.000 abstract 1
- 230000001954 sterilising effect Effects 0.000 description 67
- 239000008280 blood Substances 0.000 description 28
- 210000004369 blood Anatomy 0.000 description 28
- 238000010894 electron beam technology Methods 0.000 description 13
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 10
- 239000008103 glucose Substances 0.000 description 10
- 239000004033 plastic Substances 0.000 description 9
- 229910052751 metal Inorganic materials 0.000 description 8
- 239000002184 metal Substances 0.000 description 8
- 238000009516 primary packaging Methods 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 4
- 239000002985 plastic film Substances 0.000 description 4
- 229920006255 plastic film Polymers 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 210000003722 extracellular fluid Anatomy 0.000 description 3
- 239000011888 foil Substances 0.000 description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 239000013013 elastic material Substances 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000011176 pooling Methods 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 238000004904 shortening Methods 0.000 description 2
- 241000905957 Channa melasoma Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000012742 biochemical analysis Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 210000000624 ear auricle Anatomy 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000011133 lead Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000005022 packaging material Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 238000009832 plasma treatment Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000011896 sensitive detection Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 229920002725 thermoplastic elastomer Polymers 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
- A61L2/08—Radiation
- A61L2/087—Particle radiation, e.g. electron-beam, alpha or beta radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150015—Source of blood
- A61B5/150022—Source of blood for capillary blood or interstitial fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150206—Construction or design features not otherwise provided for; manufacturing or production; packages; sterilisation of piercing element, piercing device or sampling device
- A61B5/150274—Manufacture or production processes or steps for blood sampling devices
- A61B5/150282—Manufacture or production processes or steps for blood sampling devices for piercing elements, e.g. blade, lancet, canula, needle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150206—Construction or design features not otherwise provided for; manufacturing or production; packages; sterilisation of piercing element, piercing device or sampling device
- A61B5/150312—Sterilisation of piercing elements, piercing devices or sampling devices
- A61B5/150335—Sterilisation of piercing elements, piercing devices or sampling devices by radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150358—Strips for collecting blood, e.g. absorbent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150374—Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
- A61B5/150381—Design of piercing elements
- A61B5/150412—Pointed piercing elements, e.g. needles, lancets for piercing the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150374—Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
- A61B5/150381—Design of piercing elements
- A61B5/150442—Blade-like piercing elements, e.g. blades, cutters, knives, for cutting the skin
- A61B5/15045—Blade-like piercing elements, e.g. blades, cutters, knives, for cutting the skin comprising means for capillary action
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150374—Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
- A61B5/150381—Design of piercing elements
- A61B5/150503—Single-ended needles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150374—Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
- A61B5/150534—Design of protective means for piercing elements for preventing accidental needle sticks, e.g. shields, caps, protectors, axially extensible sleeves, pivotable protective sleeves
- A61B5/150541—Breakable protectors, e.g. caps, shields or sleeves, i.e. protectors separated destructively, e.g. by breaking a connecting area
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150374—Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
- A61B5/150534—Design of protective means for piercing elements for preventing accidental needle sticks, e.g. shields, caps, protectors, axially extensible sleeves, pivotable protective sleeves
- A61B5/150572—Pierceable protectors, e.g. shields, caps, sleeves or films, e.g. for hygienic purposes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150374—Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
- A61B5/150534—Design of protective means for piercing elements for preventing accidental needle sticks, e.g. shields, caps, protectors, axially extensible sleeves, pivotable protective sleeves
- A61B5/150633—Protective sleeves which are axially extensible, e.g. sleeves connected to, or integrated in, the piercing or driving device; pivotable protective sleeves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150374—Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
- A61B5/150534—Design of protective means for piercing elements for preventing accidental needle sticks, e.g. shields, caps, protectors, axially extensible sleeves, pivotable protective sleeves
- A61B5/150694—Procedure for removing protection means at the time of piercing
- A61B5/150702—Procedure for removing protection means at the time of piercing fully automatically removed, i.e. the removing does not require any action by the user
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150374—Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
- A61B5/150534—Design of protective means for piercing elements for preventing accidental needle sticks, e.g. shields, caps, protectors, axially extensible sleeves, pivotable protective sleeves
- A61B5/150694—Procedure for removing protection means at the time of piercing
- A61B5/150717—Procedure for removing protection means at the time of piercing manually removed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/151—Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
- A61B5/15101—Details
- A61B5/15126—Means for controlling the lancing movement, e.g. 2D- or 3D-shaped elements, tooth-shaped elements or sliding guides
- A61B5/1513—Means for controlling the lancing movement, e.g. 2D- or 3D-shaped elements, tooth-shaped elements or sliding guides comprising linear sliding guides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
- A61B2010/0003—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements including means for analysis by an unskilled person
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/08—Accessories or related features not otherwise provided for
- A61B2090/0813—Accessories designed for easy sterilising, i.e. re-usable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1486—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using enzyme electrodes, e.g. with immobilised oxidase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/151—Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
- A61B5/15186—Devices loaded with a single lancet, i.e. a single lancet with or without a casing is loaded into a reusable drive device and then discarded after use; drive devices reloadable for multiple use
- A61B5/15188—Constructional features of reusable driving devices
- A61B5/15192—Constructional features of reusable driving devices comprising driving means, e.g. a spring, for retracting the lancet unit into the driving device housing
- A61B5/15194—Constructional features of reusable driving devices comprising driving means, e.g. a spring, for retracting the lancet unit into the driving device housing fully automatically retracted, i.e. the retraction does not require a deliberate action by the user, e.g. by terminating the contact with the patient's skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2202/00—Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
- A61L2202/20—Targets to be treated
- A61L2202/22—Blood or products thereof
Definitions
- carrier-bound rapid tests have become established in specialized laboratories, but especially for use outside of fixed laboratories. Based on a specially developed dry chemistry, such rapid-drug-based rapid tests are easy and uncomplicated, even by laypersons, despite the often complex reactions involving sensitive reagents.
- carrier-bound rapid tests are test strips for the determination of the blood glucose content in diabetics.
- the present invention relates to a method for sterilizing integrated test elements comprising at least one detection area to be sterilized and at least one lancing area which is protected from sterilization and test elements which are produced by such a method.
- the piercing region can be provided with protection from plastic, in particular even before sterilization, since the electron beam sufficiently penetrates the plastic and sterilizes the underlying lancet and the plastic protects the piercing region from renewed contamination.
- the erfindungsge ⁇ Permitted method has the advantage that can be dispensed ver ⁇ to a production in a clean room, which significantly reduces production costs and costs.
- Selective sterilization in the context of the present invention describes processes in which specifically targeted areas of a product, in particular the lancing region, are sterilized and, at the same time, other defined regions of the product, in particular the detection region, are not sterilized.
- shielding the detection area is meant any means which ensures that the detection area on the test element is protected against the electron beam used so far that the detection chemistry located in the detection area is functional after the sterilization step.
- a preferred embodiment of the shield are shielding plates or diaphragms, preferably of metal.
- lead, iron, copper and aluminum as well as alloys thereof are suitable shielding materials.
- the shield may be located between the electron beam source and the test element, close to the conveyor on which the test elements are directed.
- a further embodiment of the invention consists in that the test elements are brought into the radiation area of a radiation source by means of a feed device.
- the supply device includes a conveyor belt or a belt on which the test elements are arranged, preferably in a directional orientation.
- the delivery device transports the test elements into the area of sterilization, e.g. B. an electron beam chamber or an irradiation tunnel, and then to the next production step.
- the test elements or their packaging are designed coherently and the test elements are brought by movement of the contiguous arrangement in the radiation area.
- the diagnostic test element can be made from strip material. In this case, lumped areas are combined into a band or belt, z.
- a preferred embodiment describes a lancing region, for. B. a Lanzetten ⁇ tip, the protection during stinging, z. As a thermoplastic elastomer, pierces and retracts back into the protection after piercing.
- the protection e.g. As a plastic cap, manu ⁇ ell before picking or removed from the test device. After use, the protection is again placed on the lancing area or the test element is provided without lancing area protection.
- An optional feature of the invention relates to a transport element which is arranged between lancing region and detection region and with which the analyte is transported from the lancing region to the detection region.
- a sample of the body fluid is. B, Blul, recovered and the analyte, z. B. blood glucose, transported to the detection area in order to be analyzed there.
- the function of the transport element is therefore to transport the analyte or even several analytes - if several analytes are to be detected - from the lancing area to the detection area.
- the capillary force is used as the driving force for transport.
- various embodiments are conceivable.
- the transport element may have a capillary.
- the transport element may hold a capillary channel or a capillary gap, it is also possible to use a type of wick.
- the transport element may be a separate component, for. Example, an additional capillary, or it may be integrated into the component of the lancing region or the detection area, for example in the form of a groove in the lancet, or as Kapil ⁇ larkanal on a test strip.
- the transport element can of course also be integrated into another component of the test element, in particular also in the protection of the lancing area.
- the present invention encompasses both a method for producing a diagnostic test element according to the features mentioned by means of selective sterilization and also a diagnostic test element produced directly by the method according to the invention, in particular according to the mentioned preferred embodiments.
- Fig. 2 Selective sterilization of a diagnostic test element with partially irradiated test zone.
- Fig. 6 Principle procedure in the selective sterilization of a diagnostic test element.
- FIG. 8 Application of selective sterilization on a lancing measuring disposable with a so-called. Pooling area.
- FIG. 10 Use of selective sterilization on a diagnostic test element with a flexible membrane.
- Fig. 6 illustrates the principle of selective sterilization.
- Fig. 6a shows a test element (1) having a part to be protected (11) which is not to be irradiated and a part to be irradiated (12) to be sterilized by electron radiation.
- FIG. 6b shows a basic example of the irradiation process in an electron beam installation.
- the radiation (4) irradiates the part (12) to be irradiated of an arrangement of test elements (1) which are located in an outer packaging (13), while the part (11) to be protected is shielded by the shield (5).
- the test elements are placed on a conveyor belt (14) in the radiation area.
- the shield (5) can be attached both to the band (14) or to the outer package (13).
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Manufacturing & Machinery (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
Abstract
Description
Claims
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL05764074T PL1781173T3 (pl) | 2004-07-09 | 2005-07-07 | Sposób selektywnej sterylizacji diagnostycznych elementów testujących |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102004033219A DE102004033219A1 (de) | 2004-07-09 | 2004-07-09 | Verfahren zur selektiven Sterilisation von diagnostischen Testelementen |
PCT/EP2005/007335 WO2006005503A1 (de) | 2004-07-09 | 2005-07-07 | Verfahren zur selektiven sterilisation von diagnostischen testelementen |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1781173A1 true EP1781173A1 (de) | 2007-05-09 |
EP1781173B1 EP1781173B1 (de) | 2012-11-14 |
Family
ID=34978653
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP05764074A Not-in-force EP1781173B1 (de) | 2004-07-09 | 2005-07-07 | Verfahren zur selektiven sterilisation von diagnostischen testelementen |
Country Status (7)
Country | Link |
---|---|
US (1) | US7794654B2 (de) |
EP (1) | EP1781173B1 (de) |
JP (1) | JP4722920B2 (de) |
DE (1) | DE102004033219A1 (de) |
ES (1) | ES2399238T3 (de) |
PL (1) | PL1781173T3 (de) |
WO (1) | WO2006005503A1 (de) |
Families Citing this family (63)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6391005B1 (en) | 1998-03-30 | 2002-05-21 | Agilent Technologies, Inc. | Apparatus and method for penetration with shaft having a sensor for sensing penetration depth |
US8641644B2 (en) | 2000-11-21 | 2014-02-04 | Sanofi-Aventis Deutschland Gmbh | Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means |
US9427532B2 (en) | 2001-06-12 | 2016-08-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7344507B2 (en) | 2002-04-19 | 2008-03-18 | Pelikan Technologies, Inc. | Method and apparatus for lancet actuation |
EP1404235A4 (de) | 2001-06-12 | 2008-08-20 | Pelikan Technologies Inc | Verfahren und gerät für eine auf einer blutentnahmekartusche integrierte lanzettenvorrichtung |
DE60238119D1 (de) | 2001-06-12 | 2010-12-09 | Pelikan Technologies Inc | Elektrisches betätigungselement für eine lanzette |
US9795747B2 (en) | 2010-06-02 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
US7025774B2 (en) | 2001-06-12 | 2006-04-11 | Pelikan Technologies, Inc. | Tissue penetration device |
AU2002315177A1 (en) | 2001-06-12 | 2002-12-23 | Pelikan Technologies, Inc. | Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties |
US8337419B2 (en) | 2002-04-19 | 2012-12-25 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7981056B2 (en) | 2002-04-19 | 2011-07-19 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
US9226699B2 (en) | 2002-04-19 | 2016-01-05 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling module with a continuous compression tissue interface surface |
US7297122B2 (en) | 2002-04-19 | 2007-11-20 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7892185B2 (en) | 2002-04-19 | 2011-02-22 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
US7232451B2 (en) | 2002-04-19 | 2007-06-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7331931B2 (en) | 2002-04-19 | 2008-02-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8267870B2 (en) | 2002-04-19 | 2012-09-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling with hybrid actuation |
US7901362B2 (en) | 2002-04-19 | 2011-03-08 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7674232B2 (en) | 2002-04-19 | 2010-03-09 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7547287B2 (en) | 2002-04-19 | 2009-06-16 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8221334B2 (en) | 2002-04-19 | 2012-07-17 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8579831B2 (en) | 2002-04-19 | 2013-11-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7909778B2 (en) | 2002-04-19 | 2011-03-22 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8360992B2 (en) | 2002-04-19 | 2013-01-29 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7491178B2 (en) | 2002-04-19 | 2009-02-17 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US9314194B2 (en) | 2002-04-19 | 2016-04-19 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7892183B2 (en) | 2002-04-19 | 2011-02-22 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
US7226461B2 (en) | 2002-04-19 | 2007-06-05 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device with sterility barrier release |
US7229458B2 (en) | 2002-04-19 | 2007-06-12 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8784335B2 (en) | 2002-04-19 | 2014-07-22 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling device with a capacitive sensor |
US8702624B2 (en) | 2006-09-29 | 2014-04-22 | Sanofi-Aventis Deutschland Gmbh | Analyte measurement device with a single shot actuator |
US7976476B2 (en) | 2002-04-19 | 2011-07-12 | Pelikan Technologies, Inc. | Device and method for variable speed lancet |
US9795334B2 (en) | 2002-04-19 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US9248267B2 (en) | 2002-04-19 | 2016-02-02 | Sanofi-Aventis Deustchland Gmbh | Tissue penetration device |
US8052926B2 (en) * | 2002-12-27 | 2011-11-08 | Roche Diagnostics Operations, Inc. | Method for manufacturing a sterilized lancet integrated biosensor |
US7815579B2 (en) | 2005-03-02 | 2010-10-19 | Roche Diagnostics Operations, Inc. | Dynamic integrated lancing test strip with sterility cover |
US8574895B2 (en) | 2002-12-30 | 2013-11-05 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus using optical techniques to measure analyte levels |
US7214200B2 (en) | 2002-12-30 | 2007-05-08 | Roche Diagnostics Operations, Inc. | Integrated analytical test element |
EP1581114B1 (de) | 2002-12-30 | 2014-04-30 | Roche Diagnostics GmbH | Flexible teststreifen-lanzettenvorrichtung |
ATE476137T1 (de) | 2003-05-30 | 2010-08-15 | Pelikan Technologies Inc | Verfahren und vorrichtung zur injektion von flüssigkeit |
US7850621B2 (en) | 2003-06-06 | 2010-12-14 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
WO2006001797A1 (en) | 2004-06-14 | 2006-01-05 | Pelikan Technologies, Inc. | Low pain penetrating |
US7920906B2 (en) | 2005-03-10 | 2011-04-05 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
EP1671096A4 (de) | 2003-09-29 | 2009-09-16 | Pelikan Technologies Inc | Verfahren und apparatur für eine verbesserte probeneinfangvorrichtung |
EP1680014A4 (de) | 2003-10-14 | 2009-01-21 | Pelikan Technologies Inc | Verfahren und gerät für eine variable anwenderschnittstelle |
US9247900B2 (en) | 2004-07-13 | 2016-02-02 | Dexcom, Inc. | Analyte sensor |
US7822454B1 (en) | 2005-01-03 | 2010-10-26 | Pelikan Technologies, Inc. | Fluid sampling device with improved analyte detecting member configuration |
EP1706026B1 (de) | 2003-12-31 | 2017-03-01 | Sanofi-Aventis Deutschland GmbH | Verfahren und vorrichtung zur verbesserung der fluidströmung und der probennahme |
EP1751546A2 (de) | 2004-05-20 | 2007-02-14 | Albatros Technologies GmbH & Co. KG | Bedruckbares wassergel für biosensoren |
US9775553B2 (en) | 2004-06-03 | 2017-10-03 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a fluid sampling device |
WO2005120365A1 (en) | 2004-06-03 | 2005-12-22 | Pelikan Technologies, Inc. | Method and apparatus for a fluid sampling device |
US20070045902A1 (en) | 2004-07-13 | 2007-03-01 | Brauker James H | Analyte sensor |
US8170803B2 (en) | 2004-07-13 | 2012-05-01 | Dexcom, Inc. | Transcutaneous analyte sensor |
US8652831B2 (en) | 2004-12-30 | 2014-02-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte measurement test time |
GB0508255D0 (en) | 2005-04-25 | 2005-06-01 | Lucite Int Uk Ltd | Acrylic blends |
EP2039607A1 (de) * | 2007-09-19 | 2009-03-25 | Roche Diagnostics GmbH | Verbindungsfolien mit Laser für sterile Lanzetten |
WO2009126900A1 (en) | 2008-04-11 | 2009-10-15 | Pelikan Technologies, Inc. | Method and apparatus for analyte detecting device |
US9375169B2 (en) | 2009-01-30 | 2016-06-28 | Sanofi-Aventis Deutschland Gmbh | Cam drive for managing disposable penetrating member actions with a single motor and motor and control system |
US8965476B2 (en) | 2010-04-16 | 2015-02-24 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
PL2599505T3 (pl) | 2011-11-30 | 2014-10-31 | Hoffmann La Roche | Sposób i urządzenie sterylizacyjne do sterylizowania implantowanego czujnika |
JP7071713B2 (ja) * | 2019-02-08 | 2022-05-19 | Jfeエンジニアリング株式会社 | 電子線殺菌方法 |
JP7071714B2 (ja) * | 2019-02-08 | 2022-05-19 | Jfeエンジニアリング株式会社 | 電子線殺菌方法 |
JP7071715B2 (ja) * | 2019-02-08 | 2022-05-19 | Jfeエンジニアリング株式会社 | 電子線殺菌方法及び電子線殺菌装置 |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE8007991U1 (de) * | 1980-03-22 | 1981-04-09 | Clinicon Mannheim GmbH, 6800 Mannheim | Blutlanzettenvorrichtung zur Entnahme von Blut für Diagnosezwecke |
US4627445A (en) | 1985-04-08 | 1986-12-09 | Garid, Inc. | Glucose medical monitoring system |
US4981649A (en) * | 1988-03-25 | 1991-01-01 | Snow Brand Milk Products Co., Ltd. | Means for lid sterilization and temporal sealing |
US5009654A (en) | 1989-03-10 | 1991-04-23 | Baxter International Inc. | Sterile product and method for sterilizing and assembling such product |
DE4212315A1 (de) * | 1992-04-13 | 1993-10-14 | Boehringer Mannheim Gmbh | Blutlanzettenvorrichtung zur Entnahme von Blut für Diagnosezwecke |
DE4320463A1 (de) * | 1993-06-21 | 1994-12-22 | Boehringer Mannheim Gmbh | Blutlanzettenvorrichtung zur Entnahme von Blut für Diagnosezwecke |
JP3851380B2 (ja) * | 1996-05-16 | 2006-11-29 | グンゼ株式会社 | 光拡散性シートとその製造方法 |
US6653096B1 (en) * | 1996-07-29 | 2003-11-25 | Process Challenge Devices | Process challenge device and method |
DE69809391T2 (de) * | 1997-02-06 | 2003-07-10 | Therasense Inc | Kleinvolumiger sensor zur in-vitro bestimmung |
DE19718081A1 (de) | 1997-04-29 | 1998-11-05 | Boehringer Mannheim Gmbh | Einweg Blutlanzette |
US6191424B1 (en) * | 1998-12-03 | 2001-02-20 | I-Ax Technologies | Irradiation apparatus for production line use |
CN1315432C (zh) * | 1999-01-04 | 2007-05-16 | 泰尔茂株式会社 | 体液采集检测装置 |
US6360888B1 (en) * | 1999-02-25 | 2002-03-26 | Minimed Inc. | Glucose sensor package system |
EP1178841B1 (de) * | 1999-05-21 | 2004-07-07 | Medtronic MiniMed, Inc. | Verfahren zur schutzschaltung während einer bestrahlungssterilisation |
US6594156B1 (en) * | 2000-04-24 | 2003-07-15 | Minimed Inc. | Device and method for circuit protection during radiation sterilization |
DE10010587A1 (de) * | 2000-03-03 | 2001-09-06 | Roche Diagnostics Gmbh | System zur Bestimmung von Analytkonzentrationen in Körperflüssigkeiten |
DE10010694A1 (de) * | 2000-03-04 | 2001-09-06 | Roche Diagnostics Gmbh | Blutlanzette mit hygienischen Spitzenschutz |
CN102512183B (zh) | 2001-01-19 | 2015-01-14 | 松下健康医疗器械株式会社 | 刺血针一体型传感器、测定装置及生物传感器用盒 |
WO2002056751A2 (en) | 2001-01-22 | 2002-07-25 | Roche Diagnostics Gmbh | Lancet device having capillary action |
US20020155267A1 (en) * | 2001-02-22 | 2002-10-24 | Bader Michael John | Multi-layer hermetically sealable film |
DE10134650B4 (de) | 2001-07-20 | 2009-12-03 | Roche Diagnostics Gmbh | System zur Entnahme kleiner Körperflüssigkeitsmengen |
DE10142232B4 (de) | 2001-08-29 | 2021-04-29 | Roche Diabetes Care Gmbh | Verfahren zur Herstellung eines analytischen Hilfsmittels mit Lanzette und Testelement |
FR2838721B1 (fr) * | 2002-04-22 | 2004-12-03 | Becton Dickinson France | Emballage destine a etre utilise pour transporter des objets steriles ou a steriliser |
US20030211619A1 (en) * | 2002-05-09 | 2003-11-13 | Lorin Olson | Continuous strip of fluid sampling and testing devices and methods of making, packaging and using the same |
US20030143113A2 (en) | 2002-05-09 | 2003-07-31 | Lifescan, Inc. | Physiological sample collection devices and methods of using the same |
US7192405B2 (en) * | 2002-09-30 | 2007-03-20 | Becton, Dickinson And Company | Integrated lancet and bodily fluid sensor |
US7244264B2 (en) * | 2002-12-03 | 2007-07-17 | Roche Diagnostics Operations, Inc. | Dual blade lancing test strip |
US20070191736A1 (en) * | 2005-10-04 | 2007-08-16 | Don Alden | Method for loading penetrating members in a collection device |
-
2004
- 2004-07-09 DE DE102004033219A patent/DE102004033219A1/de not_active Ceased
-
2005
- 2005-07-07 JP JP2007519720A patent/JP4722920B2/ja not_active Expired - Fee Related
- 2005-07-07 PL PL05764074T patent/PL1781173T3/pl unknown
- 2005-07-07 ES ES05764074T patent/ES2399238T3/es active Active
- 2005-07-07 EP EP05764074A patent/EP1781173B1/de not_active Not-in-force
- 2005-07-07 WO PCT/EP2005/007335 patent/WO2006005503A1/de not_active Application Discontinuation
-
2007
- 2007-01-08 US US11/620,931 patent/US7794654B2/en not_active Expired - Fee Related
Non-Patent Citations (1)
Title |
---|
See references of WO2006005503A1 * |
Also Published As
Publication number | Publication date |
---|---|
JP2008504918A (ja) | 2008-02-21 |
JP4722920B2 (ja) | 2011-07-13 |
WO2006005503A1 (de) | 2006-01-19 |
PL1781173T3 (pl) | 2013-04-30 |
EP1781173B1 (de) | 2012-11-14 |
ES2399238T3 (es) | 2013-03-26 |
US20070176120A1 (en) | 2007-08-02 |
DE102004033219A1 (de) | 2006-02-02 |
US7794654B2 (en) | 2010-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1781173B1 (de) | Verfahren zur selektiven sterilisation von diagnostischen testelementen | |
EP1287785B1 (de) | Analytisches Hilfsmittel mit Lanzette und Testelement | |
DE60124181T2 (de) | Mikrohohlnadelpflaster | |
DE60310159T3 (de) | Vorrichtung und Verfahren zur Zufuhr und Analyse von einer physiologischen Flüssigkeit | |
DE69733836T2 (de) | Vorrichtung zur körperflüssigkeitsentnahme und -analyse | |
DE60310160T2 (de) | Streifen zur Verpackung einer Mehrzahl von Geräten zur Flüssigkeitsentnahme und Testung sowie Verfahren zur Herstellung und Verwendung des Streifens | |
DE69937338T2 (de) | Integrierte gewebeporations-, flüssigkeitssammel- und analysevorrichtung | |
EP1880671B1 (de) | Lanzettenrad | |
DE60213822T2 (de) | Entnahmevorrichtung für körperflüssigkeiten und testmedienskassette | |
DE60018796T2 (de) | Vorrichtung zur erhöhung des transdermalen flusses von probenwirkstoffen | |
EP1940289B1 (de) | Analytisches hilfsmittel mit sterilschutz für die lanzette und testkammer | |
EP1263320B1 (de) | Blutlanzette mit hygienischem spitzenschutz | |
DE60311176T2 (de) | Verfahren zur Herstellung von Vorrichtungen zur Entnahme von physiologischen Proben | |
EP1838239A1 (de) | Testeinheit für einmaluntersuchungen einer körperflüssigkeit | |
EP1714614A2 (de) | Analytisches Hilfsmittel | |
DE69728525T2 (de) | Mittels vakuum verbesserter transdermaler flüssigkeitstransport | |
WO2006100265A1 (de) | Analytisches hilfsmittel mit lanzette und testelement | |
EP2408370B1 (de) | Testvorrichtung insbesondere für blutzuckertests | |
EP2059169B1 (de) | Medizinisches hilfsmittel | |
US20100081968A1 (en) | Test Strip With Integrated Lancet | |
DE202016009190U1 (de) | Medizinische Vorrichtung zum Nachweis mindestens eines Analyten in einer Körperflüssigkeit | |
DE202016009189U1 (de) | Medizinische Vorrichtung zum Nachweis mindestens eines Analyten in einer Körperflüssigkeit | |
DE202016009188U1 (de) | Medizinische Vorrichtung zum Nachweis mindestens eines Analyten in einer Körperflüssigkeit | |
DE19946059A1 (de) | System zur transdermalen Gewinnung von Körperflüssigkeit |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20070209 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: FIEDLER, WOLFGANG Inventor name: SCHWIND, KARIN |
|
DAX | Request for extension of the european patent (deleted) | ||
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: F.HOFFMANN-LA ROCHE AG Owner name: ROCHE DIAGNOSTICS GMBH |
|
17Q | First examination report despatched |
Effective date: 20081223 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R081 Ref document number: 502005013255 Country of ref document: DE Owner name: ROCHE DIABETES CARE GMBH, DE Free format text: FORMER OWNERS: ROCHE DIAGNOSTICS GMBH, 68305 MANNHEIM, DE; F. HOFFMANN-LA ROCHE AG, 4070 BASEL, CH |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D Free format text: NOT ENGLISH |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP Ref country code: AT Ref legal event code: REF Ref document number: 583527 Country of ref document: AT Kind code of ref document: T Effective date: 20121115 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D Free format text: LANGUAGE OF EP DOCUMENT: GERMAN |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 502005013255 Country of ref document: DE Effective date: 20130110 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2399238 Country of ref document: ES Kind code of ref document: T3 Effective date: 20130326 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: T3 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20121114 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20121114 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20121114 |
|
REG | Reference to a national code |
Ref country code: PL Ref legal event code: T3 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130215 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20121114 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130314 Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20121114 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20121114 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130214 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20121114 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20121114 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20121114 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20121114 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20121114 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20130815 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 502005013255 Country of ref document: DE Effective date: 20130815 |
|
BERE | Be: lapsed |
Owner name: ROCHE DIAGNOSTICS G.M.B.H. Effective date: 20130731 Owner name: F.HOFFMANN-LA ROCHE A.G. Effective date: 20130731 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20121114 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130731 Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130731 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130731 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130707 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MM01 Ref document number: 583527 Country of ref document: AT Kind code of ref document: T Effective date: 20130707 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130707 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20121114 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130707 Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20050707 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R081 Ref document number: 502005013255 Country of ref document: DE Owner name: ROCHE DIABETES CARE GMBH, DE Free format text: FORMER OWNER: ROCHE DIAGNOSTICS GMBH, 68305 MANNHEIM, DE |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 12 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20121114 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 13 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 14 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20200717 Year of fee payment: 16 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20210625 Year of fee payment: 17 Ref country code: NL Payment date: 20210618 Year of fee payment: 17 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: PL Payment date: 20210628 Year of fee payment: 17 Ref country code: GB Payment date: 20210629 Year of fee payment: 17 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20210805 Year of fee payment: 17 Ref country code: DE Payment date: 20210616 Year of fee payment: 17 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210707 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 502005013255 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MM Effective date: 20220801 |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20220707 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220731 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220707 Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230201 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220801 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20230825 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220708 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220707 |